These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7669748)

  • 1. Assessment of production of endothelium-derived relaxing factor by cultured porcine cerebral microvessel endothelial cells.
    Kishimoto T; Oguri T; Matsumura K; Kawamoto K; Tada M
    Hum Cell; 1995 Mar; 8(1):19-24. PubMed ID: 7669748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Jidoi J; Tada M
    Hum Cell; 1994 Mar; 7(1):68-71. PubMed ID: 8025024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Tada M
    Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper enhances EDNO (endothelium-derived nitric oxide) activity by cultured human vascular endothelial cells.
    Kishimoto T; Oguri T; Ueda D; Tada M
    Hum Cell; 1996 Jun; 9(2):117-24. PubMed ID: 9183639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.
    Alheid U; Frölich JC; Förstermann U
    Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of endothelium-derived relaxing factor from human coronary arteries using the anti-platelet aggregatory effect.
    Kishimoto T; Fukuzawa Y; Abe M; Hashimoto M; Tada M
    Nihon Eiseigaku Zasshi; 1992 Feb; 46(6):1043-50. PubMed ID: 1556827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cadmium (CdCl2) on cell proliferation and production of EDRF (endothelium-derived relaxing factor) by cultured human umbilical arterial endothelial cells.
    Kishimoto T; Oguri T; Ohno M; Matsubara K; Yamamoto K; Tada M
    Arch Toxicol; 1994; 68(9):555-9. PubMed ID: 7998821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.
    Schini VB; Boulanger C; Regoli D; Vanhoutte PM
    J Pharmacol Exp Ther; 1990 Feb; 252(2):581-5. PubMed ID: 2156053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.
    Macdonald PS; Read MA; Dusting GJ
    Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of SIN 1 on the interactions of endothelial cells and thrombocytes].
    Kirchmaier CM; Altorjay I; Bellinger O; Breddin HK
    Z Kardiol; 1991; 80 Suppl 5():13-6. PubMed ID: 1776329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells.
    Minuz P; Lechi C; Gaino S; Bonapace S; Fontana L; Garbin U; Paluani F; Cominacini L; Zatti M; Lechi A
    Thromb Haemost; 1995 Oct; 74(4):1175-9. PubMed ID: 8560431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
    Alheid U; Reichwehr I; Förstermann U
    Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor production in bovine cerebral microvascular endothelial cells and its drug inhibition.
    Sun DX; Huang TG; Zeng GQ; Rui YC
    Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):26-30. PubMed ID: 8503282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability.
    Oliver JA
    J Cell Physiol; 1992 Jun; 151(3):506-11. PubMed ID: 1363553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.